Stefan De Wachter

Klinikum Passau

Papers

1

Total Citations

152

H-Index

1

About

Stefan De Wachter is a leading figure in radiation oncology, whose research has fundamentally advanced the practice of stereotactic body radiotherapy (SBRT) for treating oligometastatic disease. His primary contributions lie in establishing evidence-based patterns of care and identifying key prognostic factors for SBRT, particularly for liver metastases. As a driving force behind the German Society for Radiation Oncology (DEGRO) SBRT database initiative, he orchestrated a landmark pooled analysis of 474 patients with 623 liver metastases. This highly influential work (152 citations) provided crucial, real-world data on treatment outcomes and helped standardize SBRT protocols across multiple institutions. By systematically analyzing factors that influence local tumor control and overall survival, De Wachter has directly shaped clinical decision-making, enabling more precise and effective radiotherapy for patients with limited metastatic spread. His work is essential reading for any radiation oncologist or researcher seeking to understand the modern role of SBRT in the curative-intent management of oligometastatic cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
152
Total Citations
152
Avg Citations/Paper
🏆 Most Cited Paper
The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases
152 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Klinikum Passau

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago